Status:
COMPLETED
Intranasal Dexmedetomidine VS Oral Chloral Hydrate for Rescue Sedation During Magnetic Resonance Imaging
Lead Sponsor:
Guangzhou Women and Children's Medical Center
Conditions:
Administration Related Reaction
Failed Moderate Sedation During Procedure
Eligibility:
All Genders
1-6 years
Phase:
PHASE4
Brief Summary
The purpose of this investigation was to test the hypothesis that intranasal dexmedetomidine is as effective as second dose of oral chloral hydrate for rescue sedation in infant age between 1 and 6 mo...
Eligibility Criteria
Inclusion
- 160 children of ASA physical status I or II, aged between 1 and 6 months, failed chloral hydrate sedation during MRI scanning
Exclusion
- known allergy or hypersensitive reaction to dexmedetomidine or CH, organ dysfunction, pneumonia, acute upper respiratory airway inflammation, preterm, cardiac arrhythmia or and congenital heart disease.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT02239445
Start Date
September 1 2014
End Date
May 1 2015
Last Update
May 12 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology of Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, China, 510000
2
Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, China